{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T06:29:32Z","timestamp":1775197772872,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Nagasaki University World-Leading Innovative and Smart Education (WISE) Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Med Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Yellow fever surveillance systems are designed to identify cases of acute febrile jaundice, a clinical syndrome used to monitor the emergence of yellow fever outbreaks. However, this syndrome has diverse etiologies, particularly viral hepatitis. This study investigates the seroepidemiology of viral hepatitis A (HAV), B (HBV), C (HCV), and E (HEV) among cases initially suspected to be yellow fever, aiming to elucidate the epidemiology of viral hepatitis in the Democratic Republic of Congo (DRC) and provide insights for improving public health interventions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A retrospective cross-sectional study was conducted using serum samples collected between 2017 and 2018 through national yellow fever surveillance in the DRC. Samples from individuals testing negative for yellow fever were tested for IgM antibodies against HAV, HBc, HCV, and HEV and HBs antigen using validated ELISA kits. Acute HBV infection was defined by both HBc IgM and HBs antigen positivity. Multivariable logistic regression was used to assess the association of demographic, geographic, and environmental factors with each hepatitis type.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among 1239 participants (58.8% male; median age: 16\u00a0years), seroprevalence was 16.1, 11.2, 5.0, and 3.1% for HAV, HBV, HCV and HEV, respectively. HAV prevalence was highest in the youngest age group and rural residents. In contrast, the youngest group was most protected from HBV. HCV prevalence was highest in the oldest age groups. HEV exhibited higher prevalence during the dry season and in a humid subtropical climate. Several provinces were identified as hotspots of HAV, HCV and HEV.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Viral hepatitis is a major cause of acute febrile jaundice in the DRC with notable geographic and seasonal trends. National yellow fever surveillance is a valuable resource for understanding hepatitis epidemiology, though careful interpretation is necessary. Tailored interventions are required for mitigating the burden of viral hepatitis in each province.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41182-025-00687-8","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T13:47:27Z","timestamp":1738763247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Revealing viral hepatitis epidemiology in the Democratic Republic of Congo: insights from yellow fever surveillance reanalysis"],"prefix":"10.1186","volume":"53","author":[{"given":"Patrick","family":"Mukadi-Kakoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannick","family":"Munyeku-Bazitama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gracia","family":"Kashitu-Mujinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marguerite","family":"Manwana-Pemba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niclette","family":"Zenga-Bibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patient","family":"Okitale-Talunda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle","family":"Mbelu-Kabongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fleurette","family":"Domai-Mbuyakala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Pukuta-Simbu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Mutantu-Nsele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinao","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Makiala-Mandanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Ahuka-Mundeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koya","family":"Ariyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Jacques","family":"Muyembe-Tamfum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"issue":"1","key":"687_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41426-018-0128-8","volume":"7","author":"C Domingo","year":"2018","unstructured":"Domingo C, Charrel RN, Schmidt-Chanasit J, Zeller H, Reusken C. Yellow fever in the diagnostics laboratory. Emerg Microbes Infect. 2018;7(1):129.","journal-title":"Emerg Microbes Infect"},{"key":"687_CR2","unstructured":"World Health Organization. Yellow fever key facts: WHO; 2019 https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/yellow-fever."},{"issue":"5","key":"687_CR3","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1128\/JCM.01847-16","volume":"55","author":"S Makiala-Mandanda","year":"2017","unstructured":"Makiala-Mandanda S, Le Gal F, Ngwaka-Matsung N, Ahuka-Mundeke S, Onanga R, Bivigou-Mboumba B, et al. High prevalence and diversity of hepatitis viruses in suspected cases of yellow fever in the Democratic Republic of Congo. J Clin Microbiol. 2017;55(5):1299\u2013312.","journal-title":"J Clin Microbiol"},{"key":"687_CR4","volume-title":"Establishing syndromic surveillance and event-based surveillance systems for Zika, dengue and other arboviral diseases","author":"World Health Organization Regional Office for the Eastern M","year":"2020","unstructured":"World Health Organization Regional Office for the Eastern M. Establishing syndromic surveillance and event-based surveillance systems for Zika, dengue and other arboviral diseases. Cairo: WHO Regional Office for the Eastern Mediterranean; 2020."},{"issue":"2","key":"687_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3349\/ymj.1994.35.2.231","volume":"35","author":"JP Chung","year":"1994","unstructured":"Chung JP, Kim KW, Chi HS, Lee SI, Shin ET, Cho JH, et al. Obstructive jaundice due to compression of the common hepatic duct by right hepatic artery\u2013a case associated with the absence of the lateral segment of the left hepatic lobe. Yonsei Med J. 1994;35(2):231\u20138.","journal-title":"Yonsei Med J"},{"issue":"2","key":"687_CR6","first-page":"103","volume":"37","author":"K Chang","year":"2004","unstructured":"Chang K, Yan JJ, Lee HC, Liu KH, Lee NY, Ko WC. Acute hepatitis with or without jaundice: a predominant presentation of acute Q fever in southern Taiwan. J Microbiol Immunol Infect. 2004;37(2):103\u20138.","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"687_CR7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1186\/s12879-017-2840-8","volume":"17","author":"CLB Gadia","year":"2017","unstructured":"Gadia CLB, Manirakiza A, Tekpa G, Konamna X, Vickos U, Nakoune E. Identification of pathogens for differential diagnosis of fever with jaundice in the Central African Republic: a retrospective assessment, 2008\u20132010. BMC Infect Dis. 2017;17(1):735.","journal-title":"BMC Infect Dis"},{"key":"687_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/bios10100133","author":"B Heidt","year":"2020","unstructured":"Heidt B, Siqueira WF, Eersels K, Dili\u00ebn H, van Grinsven B, Fujiwara RT, et al. Point of care diagnostics in resource-limited settings: a review of the present and future of PoC in its most needed environment. Biosensors (Basel). 2020. https:\/\/doi.org\/10.3390\/bios10100133.","journal-title":"Biosensors (Basel)"},{"issue":"3","key":"687_CR9","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s12664-023-01403-2","volume":"42","author":"AC Anand","year":"2023","unstructured":"Anand AC, Praharaj D. Acute hepatitis in tropics: a rainbow of causes. Indian J Gastroenterol. 2023;42(3):308\u201310.","journal-title":"Indian J Gastroenterol"},{"issue":"4","key":"687_CR10","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.idc.2019.08.004","volume":"33","author":"S Lanini","year":"2019","unstructured":"Lanini S, Ustianowski A, Pisapia R, Zumla A, Ippolito G. Viral hepatitis: etiology, epidemiology, transmission, diagnostics, treatment, and prevention. Infect Dis Clin North Am. 2019;33(4):1045\u201362.","journal-title":"Infect Dis Clin North Am"},{"key":"687_CR11","volume-title":"Global hepatitis report 2024: action for access in low- and middle-income countries","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Global hepatitis report 2024: action for access in low- and middle-income countries. Geneva: WHO; 2024."},{"issue":"26","key":"687_CR12","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.3748\/wjg.v27.i26.4018","volume":"27","author":"MB Pisano","year":"2021","unstructured":"Pisano MB, Giadans CG, Flichman DM, R\u00e9 VE, Preciado MV, Valva P. Viral hepatitis update: progress and perspectives. World J Gastroenterol. 2021;27(26):4018\u201344.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"687_CR13","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1186\/s12879-019-4235-5","volume":"19","author":"J Patterson","year":"2019","unstructured":"Patterson J, Abdullahi L, Hussey GD, Muloiwa R, Kagina BM. A systematic review of the epidemiology of hepatitis A in Africa. BMC Infect Dis. 2019;19(1):651.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"687_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/livers4020013","volume":"4","author":"C Stasi","year":"2024","unstructured":"Stasi C, Milli C, Voller F, Silvestri C. The epidemiology of chronic hepatitis C: where we are now. Livers. 2024;4(2):172\u201381.","journal-title":"Livers"},{"issue":"12","key":"687_CR15","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1111\/liv.16102","volume":"44","author":"GM Kassa","year":"2024","unstructured":"Kassa GM, Walker JG, Alamneh TS, Tamiru MT, Bivegete S, Adane A, et al. Prevalence, trends, and distribution of hepatitis C virus among the general population in sub-Saharan Africa: a systematic review and meta-analysis. Liver Int. 2024;44(12):3238\u201349.","journal-title":"Liver Int"},{"key":"687_CR16","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.3389\/fmicb.2019.01425","volume":"10","author":"A Rivero-Juarez","year":"2019","unstructured":"Rivero-Juarez A, Lopez-Lopez P, Frias M, Rivero A. Hepatitis E infection in HIV-infected patients. Front Microbiol. 2019;10:1425.","journal-title":"Front Microbiol"},{"issue":"7","key":"687_CR17","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/liv.14468","volume":"40","author":"P Li","year":"2020","unstructured":"Li P, Liu J, Li Y, Su J, Ma Z, Bramer WM, et al. The global epidemiology of hepatitis E virus infection: a systematic review and meta-analysis. Liver Int. 2020;40(7):1516\u201328.","journal-title":"Liver Int"},{"key":"687_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.onehlt.2020.100186","volume":"11","author":"H Bagulo","year":"2021","unstructured":"Bagulo H, Majekodunmi AO, Welburn SC. Hepatitis E in Sub Saharan Africa\u2014a significant emerging disease. One Health. 2021;11: 100186.","journal-title":"One Health"},{"issue":"1","key":"687_CR19","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/s41598-022-05014-3","volume":"12","author":"P Thompson","year":"2022","unstructured":"Thompson P, Mpody C, Sayre W, Rigney C, Tabala M, Ravelomanana NLR, et al. Hepatitis C prevalence and quality of health services among HIV-positive mothers in the Democratic Republic of the Congo. Sci Rep. 2022;12(1):1384.","journal-title":"Sci Rep"},{"issue":"1","key":"687_CR20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4269\/ajtmh.18-0883","volume":"101","author":"P Thompson","year":"2019","unstructured":"Thompson P, Parr JB, Holzmayer V, Carrel M, Tshefu A, Mwandagalirwa K, et al. Seroepidemiology of hepatitis B in the Democratic Republic of the Congo. Am J Trop Med Hyg. 2019;101(1):226\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"687_CR21","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2022.211214","author":"BMM Sumbu","year":"2022","unstructured":"Sumbu BMM, Longo-Mbenza B, Kasongo EM, Lomamba O, Nuakafuti Y, Bambi GB, et al. Epidemiological surveillance of blood donors in Kinshasa, 2014\u20132018. Clin Lab. 2022. https:\/\/doi.org\/10.7754\/Clin.Lab.2022.211214.","journal-title":"Clin Lab"},{"issue":"1","key":"687_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tracli.2017.10.007","volume":"25","author":"BMM Sumbu","year":"2018","unstructured":"Sumbu BMM, Longo-Mbenza B, Ahuka-Mundeke S, Muwonga JM, Mvumbi-Lelo G, Maphana HM, et al. Association between the viruses of the acquired immunodeficiency syndrome and the hepatitis C virus among young blood donors in Kinshasa: retrospective analysis of 10\u00a0years. Transfus Clin Biol. 2018;25(1):26\u201334.","journal-title":"Transfus Clin Biol"},{"issue":"2","key":"687_CR23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.24837","volume":"90","author":"TA Shindano","year":"2018","unstructured":"Shindano TA, Horsmans Y, Kabamba BM. Genetic and phylogenic characterization of hepatitis B virus in the eastern part of the Democratic Republic of Congo. J Med Virol. 2018;90(2):250\u20134.","journal-title":"J Med Virol"},{"issue":"5","key":"687_CR24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10389-018-0894-8","volume":"26","author":"TA Shindano","year":"2018","unstructured":"Shindano TA, Kabinda JM, Mitashi P, Horsmans Y. Hepatitis B virus infection in the Democratic Republic of Congo: a systematic review of prevalence studies (2000\u20132016). J Public Health. 2018;26(5):595\u2013603.","journal-title":"J Public Health"},{"key":"687_CR25","volume-title":"Manual for the monitoring of yellow fever virus infection","author":"World Health Organization","year":"2004","unstructured":"World Health Organization. Manual for the monitoring of yellow fever virus infection. Geneva: Department of Immunization. WHO; 2004."},{"issue":"12","key":"687_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007029","volume":"12","author":"B Ingelbeen","year":"2018","unstructured":"Ingelbeen B, Weregemere NA, Noel H, Tshapenda GP, Mossoko M, Nsio J, et al. Urban yellow fever outbreak-Democratic Republic of the Congo, 2016: Towards more rapid case detection. PLoS Negl Trop Dis. 2018;12(12): e0007029.","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"687_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009670","volume":"15","author":"P Mukadi Kakoni","year":"2021","unstructured":"Mukadi Kakoni P, Munyeku Bazitama Y, Nepomuceno JR, Pukuta-Simbu E, Kawhata Mawika F, Kashitu Mujinga G, et al. Leptospirosis as a cause of fever associated with jaundice in the Democratic Republic of the Congo. PLoS Negl Trop Dis. 2021;15(8): e0009670.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"687_CR28","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1128\/JCM.38.5.1823-1826.2000","volume":"38","author":"DA Martin","year":"2000","unstructured":"Martin DA, Muth DA, Brown T, Johnson AJ, Karabatsos N, Roehrig JT. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol. 2000;38(5):1823\u20136.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"687_CR29","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/microbiolres12040064","volume":"12","author":"FH Yandai","year":"2021","unstructured":"Yandai FH, Traore KA, Moussa AM, Ouoba BL, Ouoba JB, Bolti MA, et al. Prevalence and diversity of hepatitis virus markers among patients with acute febrile jaundice in Chad. Microbiol Res. 2021;12(4):878\u201387.","journal-title":"Microbiol Res"},{"issue":"5","key":"687_CR30","doi-asserted-by":"publisher","first-page":"314","DOI":"10.7196\/SAMJ.2019.v109i5.13410","volume":"109","author":"A Enoch","year":"2019","unstructured":"Enoch A, Hardie DR, Hussey GD, Kagina BM. Hepatitis A seroprevalence in Western Cape province, South Africa: are we in epidemiological transition? S Afr Med J. 2019;109(5):314\u20138.","journal-title":"S Afr Med J"},{"key":"687_CR31","first-page":"19","volume":"16","author":"CE Morgan","year":"2024","unstructured":"Morgan CE, Powers KA, Edwards JK, Devkota U, Biju S, Lin FC, et al. Characterizing hepatitis B virus infection in children in the Democratic Republic of Congo to inform elimination efforts. medRxiv. 2024;16:19.","journal-title":"medRxiv"},{"issue":"4","key":"687_CR32","doi-asserted-by":"publisher","first-page":"ofae150","DOI":"10.1093\/ofid\/ofae150","volume":"11","author":"CE Morgan","year":"2024","unstructured":"Morgan CE, Ngimbi P, Boisson-Walsh AJN, Ntambua S, Matondo J, Tabala M, et al. Hepatitis B virus prevalence and transmission in the households of pregnant women in Kinshasa, Democratic Republic of Congo. Open Forum Infect Dis. 2024;11(4):ofae150.","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"687_CR33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.trstmh.2005.12.003","volume":"101","author":"TA Madani","year":"2007","unstructured":"Madani TA. Trend in incidence of hepatitis B virus infection during a decade of universal childhood hepatitis B vaccination in Saudi Arabia. Trans R Soc Trop Med Hyg. 2007;101(3):278\u201383.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"687_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.vaccine.2013.11.004","volume":"32","author":"TH Nguyen","year":"2014","unstructured":"Nguyen TH, Vu MH, Nguyen VC, Nguyen LH, Toda K, Nguyen TN, et al. A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination. Vaccine. 2014;32(2):217\u201322.","journal-title":"Vaccine"},{"issue":"9","key":"687_CR35","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/01.inf.0000177279.72993.d5","volume":"24","author":"CW Shepard","year":"2005","unstructured":"Shepard CW, Finelli L, Fiore AE, Bell BP. Epidemiology of hepatitis B and hepatitis B virus infection in United States children. Pediatr Infect Dis J. 2005;24(9):755\u201360.","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"687_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003068","volume":"17","author":"AL McNaughton","year":"2020","unstructured":"McNaughton AL, Louren\u00e7o J, Bester PA, Mokaya J, Lumley SF, Obolski U, et al. Hepatitis B virus seroepidemiology data for Africa: modelling intervention strategies based on a systematic review and meta-analysis. PLoS Med. 2020;17(4): e1003068.","journal-title":"PLoS Med"},{"issue":"10","key":"687_CR37","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/apt.13795","volume":"44","author":"E Keane","year":"2016","unstructured":"Keane E, Funk AL, Shimakawa Y. Systematic review with meta-analysis: the risk of mother-to-child transmission of hepatitis B virus infection in sub-Saharan Africa. Aliment Pharmacol Ther. 2016;44(10):1005\u201317.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"687_CR38","first-page":"2181","volume":"51","author":"S Sabeena","year":"2022","unstructured":"Sabeena S, Ravishankar N. Horizontal modes of transmission of hepatitis B virus (HBV): a systematic review and meta-analysis. Iran J Public Health. 2022;51(10):2181\u201393.","journal-title":"Iran J Public Health"},{"key":"687_CR39","volume-title":"Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy. Geneva: WHO; 2020."},{"key":"687_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.puhe.2016.06.017","volume":"139","author":"BA Muzembo","year":"2016","unstructured":"Muzembo BA, Akita T, Matsuoka T, Tanaka J. Systematic review and meta-analysis of hepatitis C virus infection in the Democratic Republic of Congo. Public Health. 2016;139:13\u201321.","journal-title":"Public Health"},{"key":"687_CR41","first-page":"43","volume":"35","author":"PG Iradukunda","year":"2020","unstructured":"Iradukunda PG, Habyarimana T, Niyonzima FN, Uwitonze AY, Mpunga T. Risk factors associated with hepatitis B and C in rural population of Burera district, Rwanda. Pan Afr Med J. 2020;35:43.","journal-title":"Pan Afr Med J"},{"issue":"6","key":"687_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0306292","volume":"19","author":"ADJ Siaw","year":"2024","unstructured":"Siaw ADJ, Amugsi J, Owusu-Konadu MAA, Drah ST, Imbeah EG, Oduro-Donkor D, et al. Prevalence and risk factors of Hepatitis C virus infection in the Upper East Region of Ghana; a community-based cross-sectional study. PLoS ONE. 2024;19(6): e0306292.","journal-title":"PLoS ONE"},{"issue":"2","key":"687_CR43","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/liv.12617","volume":"35","author":"EM El-Ghitany","year":"2015","unstructured":"El-Ghitany EM, Abdel Wahab MM, Abd El-Wahab EW, Hassouna S, Farghaly AG. A comprehensive hepatitis C virus risk factors meta-analysis (1989\u20132013): do they differ in Egypt? Liver Int. 2015;35(2):489\u2013501.","journal-title":"Liver Int"},{"key":"687_CR44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/v11060554","volume":"11","author":"C Dimeglio","year":"2019","unstructured":"Dimeglio C, Kania D, Mantono JM, Kagone T, Zida S, Tassembedo S, et al. Hepatitis E virus infections among patients with acute febrile jaundice in Burkina Faso. Viruses. 2019;11:6.","journal-title":"Viruses"},{"issue":"2","key":"687_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0298723","volume":"19","author":"AF Modiyinji","year":"2024","unstructured":"Modiyinji AF, Tankeu LTA, Monamele CG, Yifomnjou Moumbeket MH, Tagnouokam Ngoupo PA, Tchetgna Simo H, et al. Hepatitis E virus infections among patients with acute febrile jaundice in two regions of Cameroon: first molecular characterization of hepatitis E virus genotype 4. PLoS ONE. 2024;19(2): e0298723.","journal-title":"PLoS ONE"},{"issue":"1","key":"687_CR46","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12879-020-04961-4","volume":"20","author":"V Tricou","year":"2020","unstructured":"Tricou V, Bouscaillou J, Laghoe-Nguembe GL, B\u00e9r\u00e9 A, Konamna X, S\u00e9l\u00e9kon B, et al. Hepatitis E virus outbreak associated with rainfall in the Central African Republic in 2008\u20132009. BMC Infect Dis. 2020;20(1):260.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"687_CR47","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12879-022-07127-6","volume":"22","author":"H Bagulo","year":"2022","unstructured":"Bagulo H, Majekodunmi AO, Welburn SC, Bimi L. Hepatitis E seroprevalence and risk factors in humans and pig in Ghana. BMC Infect Dis. 2022;22(1):132.","journal-title":"BMC Infect Dis"},{"key":"687_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.onehlt.2024.100857","volume":"19","author":"LC Cao","year":"2024","unstructured":"Cao LC, Ha LNN, Giang TT, Tiep VM, Chau NTM, Phuong Anh TN, et al. Characterization of zoonotic hepatitis E virus in domestic pigs and wild boar in Vietnam: implications for public health. One Health. 2024;19: 100857.","journal-title":"One Health"}],"container-title":["Tropical Medicine and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00687-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41182-025-00687-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00687-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T22:42:39Z","timestamp":1738795359000},"score":1,"resource":{"primary":{"URL":"https:\/\/tropmedhealth.biomedcentral.com\/articles\/10.1186\/s41182-025-00687-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["687"],"URL":"https:\/\/doi.org\/10.1186\/s41182-025-00687-8","relation":{},"ISSN":["1349-4147"],"issn-type":[{"value":"1349-4147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"11 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Institute of Tropical Medicine, Nagasaki University (Approval No. 230615290) and conducted in accordance with the ethical principles outlined in the 1964 Declaration of Helsinki. This study was part of the DRC Ministry of Public Health's Yellow Fever Surveillance Initiative, conducted by the Institut National de Recherche Biom\u00e9dicale (INRB), with authorization from the DRC Ministry of Health. It aims to enhance the utilization of yellow fever surveillance data in the DRC using anonymized samples and data without personal identifiers, thus negating the need for informed consent. This retrospective study design ensured participant privacy and confidentiality and adhered to the ethical guidelines for medical research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}